Long-acting agents for HIV treatment and prevention

被引:3
|
作者
Bekker, Linda-Gail [1 ,2 ]
机构
[1] Univ Cape Town, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, Cape Town, South Africa
[2] Univ Cape Town, Dept Med, Cape Town, South Africa
关键词
LENACAPAVIR;
D O I
10.1038/s41591-022-01917-w
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Infrequently dosed, longer-acting antiretroviral agents are making adherence to medication easier, leading to better outcomes for those living with HIV or at risk of infection.
引用
收藏
页码:1542 / 1543
页数:2
相关论文
共 50 条
  • [31] Are we ready for long-acting HIV treatment for adolescents?
    Rakhmanina, Natella
    [J]. LANCET HIV, 2024, 11 (04): : e200 - e201
  • [32] Long-acting approaches for delivery of antiretroviral drugs for prevention and treatment of HIV: a review of recent research
    Cobb, Denise A.
    Smith, Nathan A.
    Edagwa, Benson J.
    McMillan, JoEllyn M.
    [J]. EXPERT OPINION ON DRUG DELIVERY, 2020, 17 (09) : 1227 - 1238
  • [33] Advances in long-acting slow effective release antiretroviral therapies for treatment and prevention of HIV infection
    Nayan, Mohammad Ullah
    Sillman, Brady
    Hasan, Mahmudul
    Deodhar, Suyash
    Das, Srijanee
    Sultana, Ashrafi
    Le, Nam Thai Hoang
    Soriano, Vicente
    Edagwa, Benson
    Gendelman, Howard E.
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2023, 200
  • [34] Introduction: long-acting antiretrovirals for the treatment and prevention of HIV-1 infection: the future is now
    Markowitz, Martin
    [J]. CURRENT OPINION IN HIV AND AIDS, 2020, 15 (01) : 1 - 3
  • [35] Promise, perils and cautious optimism: the next frontier in long-acting modalities for the treatment and prevention of HIV
    Philbin, Morgan M.
    Perez-Brumer, Amaya
    [J]. CURRENT OPINION IN HIV AND AIDS, 2022, 17 (02) : 72 - 88
  • [36] Long-acting antiretrovirals: a new era for the management and prevention of HIV infection
    Thoueille, Paul
    Choong, Eva
    Cavassini, Matthias
    Buclin, Thierry
    Decosterd, Laurent A.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (02) : 290 - 302
  • [37] Planning ahead for implementation of long-acting HIV prevention: challenges and opportunities
    Meyers, Kathrine
    Golub, Sarit A.
    [J]. CURRENT OPINION IN HIV AND AIDS, 2015, 10 (04) : 290 - 295
  • [38] Long-Acting Cabotegravir for HIV Prevention Issues of Access, Cost, and Equity
    Sharfstein, Joshua M.
    Killelea, Amy
    Dangerfield, Derek
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (10): : 921 - 922
  • [39] USE OF LONG-ACTING OXYTETRACYCLINE IN THE TREATMENT AND PREVENTION OF BOVINE PINKEYE
    GEORGE, LW
    SMITH, JA
    KASWAN, R
    [J]. JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 1983, 183 (03) : 344 - 344
  • [40] Long-Acting HIV Treatment Superior to Daily Oral Drugs
    Harris, Emily
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 331 (12): : 1001 - 1002